Evidence map›Paper›PMID 38999069›Full record

ReviewMolecules (Basel, Switzerland)2024

Antibiotic Alternatives: Multifunctional Ultra-Small Metal Nanoclusters for Bacterial Infectious Therapy Application.

Yuxian Wang, Meng Gu, Jiangyang Cheng, Yusong Wan, Liying Zhu, Zhen Gao, Ling Jiang

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Proteomic Analysis ofAntibiotics (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuxian WangCollege of Food Science and Light Industry, Nanjing Tech University, Nanjing 211816, China.
Meng GuCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211816, China.
Jiangyang ChengCollege of Food Science and Light Industry, Nanjing Tech University, Nanjing 211816, China.
Yusong WanCollege of Food Science and Light Industry, Nanjing Tech University, Nanjing 211816, China.
Liying ZhuSchool of Chemistry and Molecular Engineering, Nanjing Tech University, Nanjing 211816, China.
Zhen GaoCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211816, China.
Ling JiangState Key Laboratory of Materials-Oriented Chemical Engineering, College of Food Science and Light Industry, Nanjing Tech University, Nanjing 211816, China.ORCID 0000-0001-6625-5557

Funding

Jiangsu Synergetic Innovation Center for Advanced Bio-Manufacture XTC2205National Natural Science Foundation of China 2021YFC2102700, U2106228the College Students' Innovative Entrepreneurial Training Plan Program 2024102911518the Jiangsu Funding Program for Excellent Postdoctoral Talent 2023ZB025the Natural Science Foundation of the Jiangsu Higher Education Institutions of China 23KJB550007the Project funded by China Postdoctoral Science Foundation 2023M741669
6 · The paper itself

Abstract

The prevalence of major bacterial infections has emerged as a significant menace to human health and life. Conventional treatment methods primarily rely on antibiotic therapy, but the overuse of these drugs has led to a decline in their efficacy. Moreover, bacteria have developed resistance towards antibiotics, giving rise to the emergence of superbugs. Consequently, there is an urgent need for novel antibacterial agents or alternative strategies to combat bacterial infections. Nanoantibiotics encompass a class of nano-antibacterial materials that possess inherent antimicrobial activity or can serve as carriers to enhance drug delivery efficiency and safety. In recent years, metal nanoclusters (M NCs) have gained prominence in the field of nanoantibiotics due to their ultra-small size (less than 3 nm) and distinctive electronic and optical properties, as well as their biosafety features. In this review, we discuss the recent progress of M NCs as a new generation of antibacterial agents. First, the main synthesis methods and characteristics of M NCs are presented. Then, we focus on reviewing various strategies for detecting and treating pathogenic bacterial infections using M NCs, summarizing the antibacterial effects of these nanoantibiotics on wound infections, biofilms, and oral infections. Finally, we propose a perspective on the remaining challenges and future developments of M NCs for bacterial infectious therapy.

Indexed as

Anti-Bacterial AgentsBacterial InfectionsMetal NanoparticlesAnimalsBacteriaBiofilmsHumansAnti-Bacterial Agentsantibacterial effectantibiotic alternativesbacterial infectious therapymetal nanoclustersnanoantibiotics

Identifiers

PMID38999069
PMCPMC11243084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.